PerspectiveImmunology

Considering Therapeutic Antibodies

See allHide authors and affiliations

Science  21 Jul 2006:
Vol. 313, Issue 5785, pp. 308-309
DOI: 10.1126/science.1130482

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Unexpected dangerous side effects of antibody-based therapies may be prevented with improved design of monoclonal antibodies and of clinical testing protocols.